Filing metadata

Accession number
0001209191-14-042815
Form type
Form 3
Filer
Eiger BioPharmaceuticals, Inc.
CIK
CIK 1305253
Filed
Jun 20, 2014
Reporting period
Jun 19, 2014
Description
Initial ownership

Explore SEC Filings Hub